Worth reading
47Recurring
Scored from 3 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
133500
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Issuance of Stock Options (Stock Acquisition Rights)
Who receives how much
133,500 common shares of the Company (133,500 share acquisition rights, with 1 share underlying each right)
3 directors, 133,500 rights
The lower thin line represents the existing number of shares to which these shares will be added.
No consideration
Terms of the stock acquisition rights
Exercise price
USD 1.36 per right (for 1 share), approximately ¥219. Adjustment provisions: Not disclosed
Exercise period
10 years from the issuance date of the share acquisition rights
Number of Stock Acquisition Rights
Total issued: 133,500 rights; unexercised balance: Not disclosed
Conditions on transfer restrictions
Restricted stock is stock awarded as compensation that cannot be sold during a specified period, with the restrictions lifted once the applicable conditions are met.
Conditions for lifting transfer restrictions
The rights may not be transferred, except in cases such as inheritance. Transfers in cases such as inheritance also require the approval of the Board of Directors.
Categories and Number of Persons Covered
3 directors of the Company, 133,500 rights
Basis for determining the amount to be paid
The closing price of the Company's common shares on the NASDAQ Global Market on 23 June 2026, the same date as the issuance date of the share acquisition rights
Procedures under the Corporate Code of Conduct
The plan was adopted by a resolution of the Board of Directors on 26 April 2023, and shareholder approval was obtained on 13 June 2023.
| Item | Details |
|---|---|
| Type of issuance or disposal | Issuance of Stock Options (Stock Acquisition Rights) |
| Number of shares to be issued or disposed of | 133,500 common shares of the Company (133,500 share acquisition rights, with 1 share underlying each right) |
| Issue price and disposal price | No consideration |
| Intended allottee | 3 directors, 133,500 rights |
| Basis for determining the amount to be paid | The closing price of the Company's common shares on the NASDAQ Global Market on 23 June 2026, the same date as the issuance date of the share acquisition rights |
| Exercise price | USD 1.36 per right (for 1 share), approximately ¥219. Adjustment provisions: Not disclosed |
| Exercise period | 10 years from the issuance date of the share acquisition rights |
| Number of Stock Acquisition Rights | Total issued: 133,500 rights; unexercised balance: Not disclosed |
| Conditions for lifting transfer restrictions | The rights may not be transferred, except in cases such as inheritance. Transfers in cases such as inheritance also require the approval of the Board of Directors. |
| Categories and Number of Persons Covered | 3 directors of the Company, 133,500 rights |
| Procedures under the Corporate Code of Conduct | The plan was adopted by a resolution of the Board of Directors on 26 April 2023, and shareholder approval was obtained on 13 June 2023. |
Items this document does not state (17)
Total issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyDilution RateTotal number of issued sharesTransfer restriction periodReason for acquisition without considerationTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMost recent equity financingMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To secure and retain the services of the eligible recipients through the grant of compensation, motivate them to work toward the success of the Company and its affiliates, and provide them with an opportunity to benefit from increases in the value of the common shares.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.